We would love to hear your thoughts about our site and services, please take our survey here.
Soft-launch = not many sold. Its a test and learn exercise with a small number of customers, from what I understand, that feeds into the review of the end-to-end process before full launch later this year.
DYOR
I believe the answers to your questions are quite straight forward:
Question 1:
What are you going to do about the share price to bring value to the shareholder? MMs control the price and spread. the board has no influence and will simply focus on achieving objectives and the SP will take care of itself. PM has said this many times, and you will not get any other response other than this.
Question 2:
Why are the new products late and why have you not apologised or provided any explanation to the market about that? They are soft-launch since July, as has been said several times. They are not 'late' per se, so don't think there is any need to apologise...
Question 3:
Why is there no marketing and sales strategy for the wellness products? There is, as part of the soft launch but that's kept under-wraps . And there is clearly a plan to launch / market / sell when fully launched later this year as mentioned in the report.
Question 4:
What will be different in regards to the release of the next line of products, to the first batch which you clearly haven’t managed to sell well? It's a soft launch - as per RNS today.
I can't imagine Mercia will be too happy with their investment since they took a large position in 2018.
Sadly, I don't think it will get any better but hope I am proved wrong. A buyout would at least be something....
DYOR
DYOR
Yes, saw the news on Lloyds Pharmacy. Will clearly have an impact on MHC, if they close down. However, that will leave an opportunity for someone else to come in and fill the gap, as there will always be a need for pharmacies. So, you just seek further contracts with others, including online pharmacies. Pivoting to other opportunities is not a bad thing...
DYOR
I raised the issue of the need, in my opinion, to increase communication to the market, including both new and existing shareholders, in order to increase awareness and progress of MED and to also increase interest and therefore liquidity in the shares. I received a timely response direct from PK, which was good to see and which I have copied below:
"Your feedback is appreciated and understood. Rest assured, we are on the same page. I agree that MED has made good progress since IPO and we are on a solid footing to pivot forward, and that we have a very exciting year ahead. We are always actively looking at various ways and means to increase the awareness and exposure of MED (and weighing the associated cost and time), which we will continue driving forward as best possible."
Quite a lot of shade in this interview, on others. Unnecessary in my view and doesn't help the cause. Nit-picking aswell, so clearly a man who very much likes to focus on the detail and for his (and only his) pov to be the right one.
I recall a podcast he was on with HUI last year (I believe) and he was keen to be the dominant party & kept interrupting with his musings, as if his view was the only one that mattered. An interesting character imo.
DYOR
ken10 - agreed, yield is very strong and I like it.
But I do wonder if this is sustainable with reducing commodity prices, certainly in the short-term, and whether this will be paired back to support an increase in capital budget spend and/or pay-off upcoming debt repayment of c.£25m
We tend to see dividends across various industries increasing year-on-year, how likely do we see this happening here?
DYOR